Literature DB >> 1655688

Purification of lincosaminide O-nucleotidyltransferase from Streptomyces coelicolor Müller.

V P Marshall1, J E McGee, J I Cialdella, L Baczynskyj, D G Chirby, D A Yurek, W F Liggett, M S Kuo.   

Abstract

An enzyme (lincosaminide O-nucleotidyltransferase) that catalyzes 3-(5'-ribonucleotidylation) of pirlimycin and several other lincosaminide antibodies has been purified approximately 35-fold from cell-free extracts of Streptomyces coelicolor Müller NRRL 3532 (UC 5240). The crude enzyme was prepared using lysozyme and was treated with MnCl2 and (NH4)2SO4. Final purification was achieved by anion exchange chromatography. The pirlimycin reaction product was verified as being pirlimycin-3-(5'-adenylate) by NMR spectroscopy and MS. As a result of purification, this lincosaminide nucleotidylating and inactivating enzyme was separated from the macrolide phosphorylating enzyme also present in the cell-free extract.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655688     DOI: 10.7164/antibiotics.44.895

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Structural and functional plasticity of antibiotic resistance nucleotidylyltransferases revealed by molecular characterization of lincosamide nucleotidylyltransferases lnu(A) and lnu(D).

Authors:  Peter J Stogios; Elena Evdokimova; Mariya Morar; Kalinka Koteva; Gerard D Wright; Patrice Courvalin; Alexei Savchenko
Journal:  J Mol Biol       Date:  2015-04-18       Impact factor: 5.469

Review 2.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

3.  A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025.

Authors:  B Bozdogan; L Berrezouga; M S Kuo; D A Yurek; K A Farley; B J Stockman; R Leclercq
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.